跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOVIPREP POLVO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MOVIPREP POLVO PARA SOLUCION ORAL
Approved
STANDARD
MOVIPREP POLVO PARA SOLUCION ORAL
Norgine B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 14, 2025
Approval ID
9a35eb8447207670
Company
Norgine B.V.
Type
Standard
Approval Details
Approval Id
9a35eb8447207670
Drug Cima Aemps Name
MOVIPREP POLVO PARA SOLUCION ORAL
Register Number
3400937881647IP
Holder Company Name
Norgine B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/norgine-b-v
Authorization Date
2025-01-14
Dosage Form
POLVO PARA SOLUCIÓN ORAL
Dose
Combinación a dosis fijas
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Norgine B.V.
Company Detail Path
/organization/norgine-b-v
Company Information
Pharmaceutical Company Name
Norgine B.V.
Country Name
Netherlands
City Name
amsterdam,noord-holland,country_nl
Address
Antonio Vivaldistraat 150
Active Ingredients
MACROGOL 3350
100,00 g
SODIO SULFATO ANHIDRO
7,500 g
SODIO CLORURO
2,691 g
CLORURO DE POTASIO
1,015 g
ASCORBICO ACIDO
4,700 g
ASCORBATO SODIO
5,900 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 14, 2025
Approval ID
9a35eb8447207670
Type
Standard
Back to CIMA-AEMPS Approvals